Martin C Woodle Selected Research

Animal Disease Models

1/2008	Delivering small interfering RNA for novel therapeutics.
3/2005	Modulation of angiogenesis with siRNA inhibitors for novel therapeutics.
1/2005	In vivo application of RNA interference: from functional genomics to therapeutics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin C Woodle Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 06/2003
3	Animal Disease Models 01/2008 - 01/2005
2	Virus Diseases (Viral Diseases) 09/2005 - 06/2004
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Cardiomyopathies (Cardiomyopathy) 01/2019
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 09/2005
1	Severe Acute Respiratory Syndrome 09/2005
1	Arthritis (Polyarthritis) 04/2005
1	Rheumatoid Arthritis 04/2005
1	Experimental Arthritis 04/2005
1	Inflammation (Inflammations) 04/2005
1	Herpes Simplex 12/2004
1	Eye Diseases (Eye Disease) 12/2004
1	Keratitis 12/2004
1	Pathologic Neovascularization 12/2004
1	Communicable Diseases (Infectious Diseases) 06/2004
1	Infections 06/2004

Drug/Important Bio-Agent (IBA)

11	Small Interfering RNA (siRNA)IBA 01/2019 - 06/2003
6	Peptides (Polypeptides)IBA 01/2022 - 09/2014
3	Neuropilin-1IBA 01/2022 - 02/2017
3	LigandsIBA 01/2022 - 11/2004
2	Histidine (L-Histidine)FDA Link 01/2022 - 09/2014
2	Lysine (L-Lysine)FDA Link 01/2022 - 09/2014
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2018 - 02/2017
2	RNA (Ribonucleic Acid)IBA 01/2017 - 06/2004
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2004 - 11/2004
1	PolymersIBA 01/2022
1	Amino Acids FDA Link 01/2022
1	LuciferasesIBA 01/2022
1	Liposomes (Liposome)IBA 01/2018
1	liposomal doxorubicin (Doxil)FDA Link 02/2017
1	Nucleotide AptamersIBA 01/2017
1	Single-Chain AntibodiesIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	tdTomatoIBA 09/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2005
1	Therapeutic UsesIBA 04/2005
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2004
1	Vascular Endothelial Growth FactorsIBA 12/2004
1	OligodeoxyribonucleotidesIBA 12/2004
1	OligonucleotidesIBA 11/2004
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 11/2004
1	PolyethyleneimineIBA 11/2004
1	Proteins (Proteins, Gene)FDA Link 11/2004
1	IntegrinsIBA 11/2004
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 11/2004
1	arginyl-glycyl-aspartic acidIBA 11/2004
1	Antisense OligonucleotidesIBA 06/2003

Therapy/Procedure

6	Therapeutics 02/2017 - 11/2004
1	RNAi Therapeutics 01/2008
1	Intravenous Administration 11/2004